Publication:
Value of Clostridium difficile antigen test in immunocompromised hosts in the tropics.

dc.contributor.authorY. Siristonpunen_US
dc.contributor.authorD. Tanphaichitraen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-08-10T08:34:37Z
dc.date.available2018-08-10T08:34:37Z
dc.date.issued1991-01-01en_US
dc.description.abstract39 fecal and body fluid specimens of immunocompromised patients who developed diarrhoea were tested for Clostridium difficile antigen test. The test was identified in only 11 and in one ascitic fluid. Endoscopy was performed in 5 patients and it showed pseudomembranous colitis in one. Numerous antibiotics were associated with C. difficile related diarrhea: ampicillin, 43%; cephalosporins, 43% and clindamycin, 14%. Three Salmonella sp., and one Entamoeba histolytica were detected among patients who later developed C. difficile associated diarrhea. The effect of oral vancomycin and fusidic acid was demonstrated in patients with C. difficile related diarrhea or colitis. The C. difficile antigen test is promising diagnostic tool in immunocompromised hosts in the tropics where both Salmonella and E. histolytica all are endemic.en_US
dc.identifier.citationJournal of chemotherapy (Florence, Italy). Vol.3 Suppl 1, (1991), 73-75en_US
dc.identifier.issn1120009Xen_US
dc.identifier.other2-s2.0-0026102232en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/22174
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0026102232&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleValue of Clostridium difficile antigen test in immunocompromised hosts in the tropics.en_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0026102232&origin=inwarden_US

Files

Collections